Who is not eligible for psychedelic sessions under your protocols?

The contraindications for participating in psychedelic therapy at Triptherapie are clearly defined and strictly monitored, as explained in the article Why psychedelic sessions are not suitable for everyone. These limitations are in place to ensure both physical and mental safety for participants. In addition to medical considerations, psychological vulnerabilities are also carefully assessed.

The main contraindications include:

1. Active psychosis or a history of psychotic episodes. Psychedelics might worsen or re-trigger psychosis.

2. Diagnosed schizophrenia or other psychotic disorders. These conditions are incompatible with substances like psilocybin or MDMA.

3. Bipolar I disorder. Unlike Bipolar II, which may be considered under certain conditions, Bipolar I is a strict contraindication due to the risk of triggering mania.

4. Being under the age of 30 with a family history of psychosis or schizophrenia. This combination increases the risk of a first psychotic episode in those with genetic vulnerability.

5. Uncontrolled high blood pressure or cardiovascular disease. This is particularly relevant with substances like MDMA, which significantly raise blood pressure and heart rate.

6. Use of certain medications, such as MAO inhibitors or antipsychotics. These can cause dangerous interactions with psychedelics. SSRI and SNRI use is not an absolute contraindication but is evaluated on a case-by-case basis.

7. Severe borderline personality disorder. In cases of emotional instability or suicidality, sessions may cause more harm than healing. In mild and stable cases, participation may still be considered following thorough screening.

8. Severe addiction without a stable foundation. Psychedelics can support addiction recovery, but only when motivation, support, and a basic level of emotional stability are present.

9. Pregnancy or breastfeeding. Psychedelic sessions are not conducted during these periods for safety reasons.